(19)
(11) EP 3 559 036 A1

(12)

(43) Date of publication:
30.10.2019 Bulletin 2019/44

(21) Application number: 17832143.6

(22) Date of filing: 21.12.2017
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 37/00(2006.01)
 A61P 17/00(2006.01)
(86) International application number:
PCT/US2017/067988
(87) International publication number:
WO 2018/119288 (28.06.2018 Gazette 2018/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(30) Priority: 22.12.2016 US 201662437889 P
14.12.2017 EP 17306770

(71) Applicants:
  • Sanofi
    75008 Paris (FR)
  • The University of Massachusetts
    Boston, MA 02108 (US)

(72) Inventors:
  • BRONDYK, William, H.
    Bridgewater, NJ 08807 (US)
  • CHU, Ruiyin
    Bridgewater, NJ 08807 (US)
  • CONNORS, Timothy, D.
    Bridgewater, NJ 08807 (US)
  • PARK, Sunghae
    Bridgewater, NJ 08807 (US)
  • QIU, Huawei
    Bridgewater, NJ 08807 (US)
  • YOUD, Michele
    Bridgewater, NJ 08807 (US)
  • HARRIS, John
    Boston, MA 02108 (US)
  • RICHMOND, Jillian
    Boston, MA 02108 (US)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) ANTI-HUMAN CXCR3 ANTIBODIES FOR TREATMENT OF VITILIGO